Citius Pharmaceuticals, Inc. — Net Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d05df0c7-bbf1-45c8-9019-ad8b871417a5/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-32.5M | 2022-10-01 – 2023-09-30 | evidence 0001213900-23-099889 |
| FY 2022 | $-33.6M | 2021-10-01 – 2022-09-30 | evidence 0001213900-22-082217 |
| FY 2021 | $-23.1M | 2020-10-01 – 2021-09-30 | evidence 0001213900-21-065464 |
| FY 2020 | $-17.5M | 2019-10-01 – 2020-09-30 | evidence 0001213900-20-043004 |
| FY 2019 | $-15.6M | 2018-10-01 – 2019-09-30 | evidence 0001213900-19-026259 |
| FY 2018 | $-12.5M | 2017-10-01 – 2018-09-30 | evidence 0001213900-18-017214 |
| FY 2017 | $-10.4M | 2016-10-01 – 2017-09-30 | evidence 0001213900-17-013191 |
| FY 2016 | $-8.3M | 2015-10-01 – 2016-09-30 | evidence 0001477932-16-014315 |
| FY 2015 | $-2.9M | 2014-10-01 – 2015-09-30 | evidence 0001477932-15-007617 |
| FY 2014 | $-737.7k | 2013-10-01 – 2014-09-30 | evidence 0001477932-16-014315 |
| FY 2013 | $-105.6k | 2010-09-09 – 2014-03-31 | evidence 0001185185-14-001283 |
| FY 2012 | $-75.5k | 2010-09-09 – 2013-03-31 | evidence 0001185185-13-001079 |
| FY 2011 | $-51.6k | 2010-09-09 – 2012-03-31 | evidence 0001185185-12-000973 |
| FY 2010 | $-15.5k | 2009-10-01 – 2010-09-30 | evidence 0001185185-12-000067 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Citius Pharmaceuticals, Inc. — all facts · Revenue · Operating Income